BEAM (STOCKS)
Beam Therapeutics Inc. Common Stock
$30.961900
+1.931900 (+6.65%)
Prev close: $29.030000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John Evans
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,203.66M
- Employees
- 510
- P/E (TTM)
- -42.25
- P/B (TTM)
- 2.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $164.01M |
| Benefits Costs and Expenses | $229.05M |
| Costs And Expenses | $229.05M |
| Nonoperating Income/Loss | $306.58M |
| Operating Expenses | $535.63M |
| Depreciation and Amortization | $22.37M |
| Research and Development | $415.33M |
| Other Operating Expenses | $97.94M |
| Operating Income/Loss | -$371.62M |
| Income/Loss From Continuing Operations After Tax | -$65.04M |
| Income/Loss From Continuing Operations Before Tax | -$65.04M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$65.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$65.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$65.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.50 |
| Diluted Earnings Per Share | -$0.50 |
| Basic Average Shares | 309,166,334 |
| Diluted Average Shares | 309,166,334 |
| Assets | $1.48B |
| Current Assets | $1.27B |
| Cash | $1.20B |
| Other Current Assets | $66.95M |
| Noncurrent Assets | $213.85M |
| Fixed Assets | $101.25M |
| Other Non-current Assets | $112.60M |
| Liabilities | $316.36M |
| Current Liabilities | $74.57M |
| Accounts Payable | $12.29M |
| Wages | $6.68M |
| Other Current Liabilities | $55.60M |
| Noncurrent Liabilities | $241.80M |
| Long-term Debt | $100.19M |
| Other Non-current Liabilities | $141.60M |
| Equity | $1.16B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.16B |
| Liabilities And Equity | $1.48B |
| Net Cash Flow From Operating Activities | -$369.73M |
| Net Cash Flow From Operating Activities, Continuing | -$369.73M |
| Net Cash Flow From Investing Activities | $28.92M |
| Net Cash Flow From Investing Activities, Continuing | $28.92M |
| Net Cash Flow From Financing Activities | $101.28M |
| Net Cash Flow From Financing Activities, Continuing | $101.28M |
| Net Cash Flow | -$239.53M |
| Net Cash Flow, Continuing | -$239.53M |
| Comprehensive Income/Loss | -$66.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$66.27M |
| Other Comprehensive Income/Loss | -$113.81M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.23M |